(Q43122923)

14 November 2017

title

Creatine metabolism and the urea cycle (English)

1 reference

14 November 2017

John T Brosnan

1

1 reference

14 November 2017

Margaret E Brosnan

series ordinal

2

1 reference

14 November 2017

publication date

1 March 2010

1 reference

Molecular Genetics and Metabolism

14 November 2017

published in

1 reference

14 November 2017

volume

100 Suppl 1

1 reference

14 November 2017

page(s)

S49-52

1 reference

Creatine and creatinine metabolism

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Mitochondrial creatine kinase in human health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP re-cycling activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Inhibition of tumor necrosis factor-induced apoptosis in transgenic mouse liver expressing creatine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Exocytotic release of creatine in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Creatine: endogenous metabolite, dietary, and therapeutic supplement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Analysis of creatine, creatinine, creatine-d3 and creatinine-d3 in urine, plasma, and red blood cells by HPLC and GC-MS to follow the fate of ingested creatine-d3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Methyl balance and transmethylation fluxes in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Clinical characteristics and diagnostic clues in inborn errors of creatine metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Localization of L-arginine-glycine amidinotransferase protein in rat tissues by immunofluorescence microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Multiple forms of rat kidney L-arginine:glycine amidinotransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Hyperargininemia due to liver arginase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Contrasting features of urea cycle disorders in human patients and knockout mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Guanidinoacetate and creatine/creatinine levels in controls and patients with urea cycle defects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Usefulness of magnetic resonance spectroscopy in urea cycle disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: implications for treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

Secondary creatine deficiency in ornithine delta-aminotransferase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.02.020

10.1016/J.YMGME.2010.02.020

7 January 2021

Identifiers

DOI

1 reference

14 November 2017

1 reference